» Articles » PMID: 38987578

Consequences of Ionizing Radiation Exposure to the Cardiovascular System

Overview
Journal Nat Rev Cardiol
Date 2024 Jul 10
PMID 38987578
Authors
Affiliations
Soon will be listed here.
Abstract

Ionizing radiation is widely used in various industrial and medical applications, resulting in increased exposure for certain populations. Lessons from radiation accidents and occupational exposure have highlighted the cardiovascular and cerebrovascular risks associated with radiation exposure. In addition, radiation therapy for cancer has been linked to numerous cardiovascular complications, depending on the distribution of the dose by volume in the heart and other relevant target tissues in the circulatory system. The manifestation of symptoms is influenced by numerous factors, and distinct cardiac complications have previously been observed in different groups of patients with cancer undergoing radiation therapy. However, in contemporary radiation therapy, advances in treatment planning with conformal radiation delivery have markedly reduced the mean heart dose and volume of exposure, and these variables are therefore no longer sole surrogates for predicting the risk of specific types of heart disease. Nevertheless, certain cardiac substructures remain vulnerable to radiation exposure, necessitating close monitoring. In this Review, we provide a comprehensive overview of the consequences of radiation exposure on the cardiovascular system, drawing insights from various cohorts exposed to uniform, whole-body radiation or to partial-body irradiation, and identify potential risk modifiers in the development of radiation-associated cardiovascular disease.

Citing Articles

Preliminary study on the correlation between thyroid magnetic resonance parameters and radiation dose after radiotherapy for nasopharyngeal carcinoma.

Lu K, Zhou C, Ren J, Ni J, Yang W, Wang Y Front Public Health. 2025; 12():1526147.

PMID: 39850855 PMC: 11756455. DOI: 10.3389/fpubh.2024.1526147.


Assessment of Skills of Caregivers Providing Care for Stroke Patients in East Kazakhstan Region.

Kairatova G, Khismetova Z, Smailova D, Serikova-Esengeldina D, Berikuly D, Akhmetova K Healthcare (Basel). 2025; 13(1.

PMID: 39791634 PMC: 11719777. DOI: 10.3390/healthcare13010027.


Cardiovascular disease and radiopharmaceutical therapies- an underestimated risk?.

Lassmann M, Eberlein U, Verburg F Eur J Nucl Med Mol Imaging. 2025; 52(4):1246-1248.

PMID: 39743614 PMC: 11839867. DOI: 10.1007/s00259-024-07039-4.


Cardiotoxicity following thoracic radiotherapy for lung cancer.

Walls G, Bergom C, Mitchell J, Rentschler S, Hugo G, Samson P Br J Cancer. 2024; 132(4):311-325.

PMID: 39506136 PMC: 11833127. DOI: 10.1038/s41416-024-02888-0.

References
1.
Mikkelsen R, Wardman P . Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene. 2003; 22(37):5734-54. DOI: 10.1038/sj.onc.1206663. View

2.
Jiao Y, Cao F, Liu H . Radiation-induced Cell Death and Its Mechanisms. Health Phys. 2022; 123(5):376-386. PMC: 9512240. DOI: 10.1097/HP.0000000000001601. View

3.
Bentzen S . Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer. 2006; 6(9):702-13. DOI: 10.1038/nrc1950. View

4.
Mothersill C, Seymour C . Radiation-induced bystander effects--implications for cancer. Nat Rev Cancer. 2004; 4(2):158-64. DOI: 10.1038/nrc1277. View

5.
Kadhim M, Salomaa S, Wright E, Hildebrandt G, Belyakov O, Prise K . Non-targeted effects of ionising radiation--implications for low dose risk. Mutat Res. 2012; 752(2):84-98. PMC: 4091999. DOI: 10.1016/j.mrrev.2012.12.001. View